UNAIDS commends Merck’s decision to register ATRIPLA in developing countries. The registration of ATRIPLA, a once-daily single tablet regimen for treatment of HIV infection in adults, exemplifies the joint efforts of two research and development leaders, Merck Co. and Gilead Sciences to make essential medicines available to those in need.

UNAIDS mourns the death of french

The Joint United Nations Programme

Be smart – protect yourself”- The German football star and UNAIDS Special Representative Michael Ballack speaks out on HIV prevention by featuring in new public service announcement (PSA) on AIDS that urges young people to make smart choices.

The Joint United Nations Programme

One of Kenya’s leading scholars and renowned AIDS advocate and researcher, Professor Job Bwayo was killed during a shooting in the outskirts of Nairobi on Sunday 4 February.

A Phase III study of the candidate

The Joint United Nations Programme

UNAIDS responds to the report

The Joint United Nations Programme on HIV/AIDS and its Cosponsors, WHO, UNFPA, UNICEF and the World Bank, note with considerable interest today’s announcement by the US National Institutes of Health that two trials assessing the impact of male circumcision on HIV risk are being stopped on the recommendation of the NIH Data Safety and Monitoring Board (DSMB).